Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Up – What’s Next?

Ono Pharmaceutical Co. (OTCMKTS:OPHLF)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $14.71, but opened at $15.67. Ono Pharmaceutical shares last traded at $15.67, with a volume of 416 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Ono Pharmaceutical from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the company has an average rating of “Strong Buy”.

Ono Pharmaceutical Price Performance

The firm has a market capitalization of $7.52 billion, a PE ratio of 15.24 and a beta of 0.33. The company has a current ratio of 3.02, a quick ratio of 2.56 and a debt-to-equity ratio of 0.10. The company has a fifty day moving average price of $14.44 and a two-hundred day moving average price of $14.81.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research‐based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.